Sorrento Therapeutics Inc. shareholders have filed a lawsuit against the company’s CEO and the law firm Jackson Walker LLP over allegations of misconduct related to the company’s bankruptcy proceedings. The legal action, recently initiated, accuses Sorrento’s CEO, Henry Ji, and the Texas-based law firm of breaching fiduciary duties, which the shareholders claim led to financial losses.
The lawsuit highlights the complex dynamics between corporate leadership and legal counsel during critical financial downturns. Shareholders allege that the company’s decision-making was compromised, affecting its financial health and ultimately favoring particular stakeholders. The case underscores the broader responsibilities of legal advisers in corporate governance and restructuring processes, particularly in high-stakes scenarios like bankruptcy.
This legal dispute follows a challenging period for Sorrento Therapeutics, which filed for Chapter 11 bankruptcy protection earlier this year. The company faced a significant decline in its stock value amidst its financial struggles. Jackson Walker’s involvement, as outlined in the suit, has raised questions about the firm’s role and influence during the restructuring efforts.
The outcome of this case may set an important precedent regarding the accountability of corporate executives and their legal advisers during bankruptcy procedures. The full implications for corporate governance practices will depend on how the courts interpret fiduciary responsibilities and the degree of oversight required from legal counsel. Details of the lawsuit can be found in a report by Bloomberg Law.